Prothena Corporation plc (PRTA) Q4 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Prothena Corporation Plc.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.534 My name is Pam, and I will be your coordinator for today. 00:00:03.534 -- 00:00:07.057 At this time, all participants are in listen-only mode. 00:00:07.057 -- 00:00:12.602 We will be facilitating a question and answer session towards the end of today's call. 00:00:12.602 -- 00:00:17.947 If at any time during the call you require assistance, please press star, 00:00:17.947 -- 00:00:22.071 followed by zero, and a coordinator will be happy to assist you. 00:00:22.071 -- 00:00:27.335 I would now like to turn the call over to Mark Johnson, Vice President at Prisina. 00:00:27.335 -- 00:00:29.616 Please proceed. 00:00:30.997 -- 00:00:35.541 Thank you. Good afternoon, everyone, and welcome to today's call to review Procena's 00:00:35.541 -- 00:00:40.726 business progress, fourth quarter and full year 2024 financial results, and 2025 00:00:40.726 -- 00:00:45.290 financial guidance. Please review the press release we issued earlier today, which is 00:00:45.290 -- 00:00:47.953 available on our website at procena.com 00:00:47.953 -- 00:00:51.716 and is also attached to a Form 8-K filed today with the SEC. 00:00:51.716 -- 00:00:55.660 In addition, we are using supplemental slides, which are available on the Invent and 00:00:55.660 -- 00:01:00.603 Presentation section of our Investor Relations website. 00:01:00.629 -- 00:01:05.598 On today's call, Dr. Jean Kenney, our President and Chief Executive Officer, will provide 00:01:05.598 -- 00:01:09.986 opening remarks, including an overview of Prothena's corporate and development strategy. 00:01:09.986 -- 00:01:14.674 Chad Swanson, our Chief Development Officer, will provide an update on our ongoing wholly 00:01:14.674 -- 00:01:18.962 owned clinical program. And Brandon Smith, our Chief Operating Off...